Cardiovascular Disease Doctors in Meridian, MS Accepting Medicare

13 Cardiovascular Disease doctors found. Showing 1 - 13

Dr. Edwin M Purvis, M.D. Internal Medicine - Cardiovascular Disease Medicare: Accepting Medicare Assignments Practice Location: 1600 22nd Ave, Medical Towers Iii, Meridian, MS 39301 Phone: 601-483-5322    Fax: 601-581-2289

Dr. Larry Shea Shea Hailey, DO Internal Medicine - Cardiovascular Disease Medicare: Accepting Medicare Assignments Practice Location: 1600 22nd Ave, Medical Towers Iii, Meridian, MS 39301 Phone: 601-483-5322    Fax: 601-581-2289

Dr. Jennifer J Rodriguez, MD Internal Medicine - Cardiovascular Disease Medicare: Accepting Medicare Assignments Practice Location: 1800 12th St, Meridian, MS 39301 Phone: 601-703-9224    Fax: 601-703-3047

Dr. Harry Dayton, M. D., PH. D. Internal Medicine - Cardiovascular Disease Medicare: Accepting Medicare Assignments Practice Location: 905c S Frontage Rd, Meridian, MS 39301 Phone: 601-486-4210    Fax: 601-486-4219

Dr. Zaid Fakhri Altheeb, MD Internal Medicine - Cardiovascular Disease Medicare: Accepting Medicare Assignments Practice Location: 4909 Great River Drive, Meridian, MS 39305 Phone: 601-282-8980    Fax: 601-639-6561

Peter P Scalise, MD Internal Medicine - Cardiovascular Disease Medicare: Accepting Medicare Assignments Practice Location: 1800 12th St, Meridian, MS 39301 Phone: 601-703-9226

Dr. Randall Scott Joransen, M.D. Internal Medicine - Cardiovascular Disease Medicare: Accepting Medicare Assignments Practice Location: 2024 15th St Fl 2, Meridian, MS 39301 Phone: 601-553-2000    Fax: 601-553-2140

Dr. Thomas G. Plavac, M.D. Internal Medicine - Cardiovascular Disease Medicare: Accepting Medicare Assignments Practice Location: 2024 15th St Fl 2, Meridian, MS 39301 Phone: 601-553-2000    Fax: 601-693-0280

Dr. John Timothy Boyd, M.D. Internal Medicine - Cardiovascular Disease Medicare: Accepting Medicare Assignments Practice Location: 2024 15th St Fl 2, Meridian, MS 39301 Phone: 601-553-2000    Fax: 601-693-0280

Dr. Thomas M. Mcfarland, M.D. Internal Medicine - Cardiovascular Disease Medicare: Not Enrolled in Medicare Practice Location: 1800 12th St, Meridian, MS 39301 Phone: 601-703-9224    Fax: 601-703-3047

Dr. Charles W. Davenport Jr., M.D. Internal Medicine - Cardiovascular Disease Medicare: Accepting Medicare Assignments Practice Location: 1800 12th St, Meridian, MS 39301 Phone: 601-703-4065    Fax: 601-703-3050

Dr. Dale A. Touchstone, M.D. Internal Medicine - Cardiovascular Disease Medicare: Not Enrolled in Medicare Practice Location: 2024 15th St Fl 2, Meridian, MS 39301 Phone: 601-553-2000    Fax: 601-553-2140

Dr. John B Hicks, M.D. Internal Medicine - Cardiovascular Disease Medicare: Not Enrolled in Medicare Practice Location: 1213 56th St, Meridian, MS 39305 Phone: 601-483-7812    Fax: 601-482-4269

News Archive

Discovery of two important molecules that underlie the pathology of lupus, particularly kidney disease

Kidney damage associated with the autoimmune disease lupus is linked to a malfunction of immune cells that causes them to congregate in and attack the organs, researchers at UT Southwestern Medical Center have discovered in a mouse study.

Emergency department-initiated treatment better than referrals for opioid-dependent patients

Yale researchers conducted the first known randomized trial comparing three treatment strategies for opioid-dependent patients receiving emergency care. They found that patients given the medication buprenorphine were more likely to engage in addiction treatment and reduce their illicit opioid use.

Detailed picture of migraines

Every eight adult Swede suffers from migraine. Using a new method, researchers at Göteborg have managed for the first time ever to provide a detailed picture of an untreated attack. This will be of great significance for the development of new forms of treatment.

ImmunoCellular Therapeutics initiates enrollment in ICT-107 Phase II trial for GBM

ImmunoCellular Therapeutics, Ltd., a biotechnology company that is developing immune-based therapies for the treatment of various forms of cancer, announced today that the first patient has been enrolled in its Phase II trial of ICT-107 at the New Jersey Neuroscience Institute at JFK Medical Center. ICT-107 is the company's dendritic cell based cancer vaccine candidate for the treatment of glioblastoma multiforme (GBM).

Reduced incidence of invasive breast cancer with Raloxifene among women at increased coronary risk

Women who took raloxifene were less likely to develop invasive estrogen-receptor (ER) positive breast cancer compared with women who did not, according to data from a randomized controlled trial published online June 10 in the Journal of the National Cancer Institute. The drug did not reduce the risk of non-invasive cancer or invasive ER-negative cancers.

Read more Medical News

› Verified 8 days ago